Supplemental data (Tables)

12 Months Ended

Dec. 31, 2016

Condensed Financial Statements Captions [Line Items]

	DaVita Inc.			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Consolidating Adjustments			Consolidated Total
For the twelve months ended December 31, 2016
Patient services revenues	$	—		$	6,766,138		$	3,761,590		$	(173,567	)	$	10,354,161
Less: Provision for uncollectible accounts		—			(278,761	)		(172,592	)		—			(451,353	)
Net patient service revenues		—			6,487,377			3,588,998			(173,567	)		9,902,808
Capitated revenues		—			1,795,673			1,723,279			(273	)		3,518,679
Other revenues		767,791			2,089,749			125,203			(1,659,125	)		1,323,618
Total net revenues		767,791			10,372,799			5,437,480			(1,832,965	)		14,745,105
Operating expenses and charges		524,108			9,735,334			4,424,085			(1,832,965	)		12,850,562
Operating income		243,683			637,465			1,013,395			—			1,894,543
Debt expense		(407,925	)		(358,535	)		(50,710	)		402,788			(414,382	)
Other income, net		396,797			6,196			8,529			(402,788	)		8,734
Income tax expense		79,301			210,338			166,174			—			455,813
Equity earnings in subsidiaries		726,620			651,832			—			(1,378,452	)		—
Net income		879,874			726,620			805,040			(1,378,452	)		1,033,082
Less: Net income attributable to noncontrolling interests		—			—			—			(153,208	)		(153,208	)
Net income attributable to DaVita Inc.	$	879,874		$	726,620		$	805,040		$	(1,531,660	)	$	879,874

Consolidating Statements of Income

	DaVita Inc.			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Consolidating Adjustments			Consolidated Total
For twelve months ended December 31, 2015
Patient services revenues	$	—		$	6,578,185		$	3,047,048		$	(144,954	)	$	9,480,279
Less: Provision for uncollectible accounts		—			(285,454	)		(142,406	)		—			(427,860	)
Net patient service revenues		—			6,292,731			2,904,642			(144,954	)		9,052,419
Capitated revenues		—			1,776,311			1,733,027			(243	)		3,509,095
Other revenues		727,887			1,875,133			32,137			(1,414,834	)		1,220,323
Total net revenues		727,887			9,944,175			4,669,806			(1,560,031	)		13,781,837
Operating expenses and charges		488,595			9,565,667			4,116,911			(1,560,031	)		12,611,142
Operating income		239,292			378,508			552,895			—			1,170,695
Debt (expense) and refinancing charges		(449,598	)		(340,176	)		(42,500	)		375,822			(456,452	)
Other income, net		365,752			11,562			7,401			(375,822	)		8,893
Income tax expense		81,221			173,063			41,442			—			295,726
Equity earnings in subsidiaries		195,507			318,676			—			(514,183	)		—
Net income		269,732			195,507			476,354			(514,183	)		427,410
Less: Net income attributable to noncontrolling interests		—			—			—			(157,678	)		(157,678	)
Net income attributable to DaVita Inc.	$	269,732		$	195,507		$	476,354		$	(671,861	)	$	269,732
For the year ended December 31, 2014
Patient services revenues	$	—		$	6,246,683		$	2,739,204		$	(117,549	)	$	8,868,338
Less: Provision for uncollectible accounts		—			(238,600	)		(128,284	)		—			(366,884	)
Net patient service revenues		—			6,008,083			2,610,920			(117,549	)		8,501,454
Capitated revenues		—			1,681,668			1,579,804			(184	)		3,261,288
Other revenues		684,066			1,639,828			24,155			(1,315,685	)		1,032,364
Total net revenues		684,066			9,329,579			4,214,879			(1,433,418	)		12,795,106
Operating expenses and charges		443,951			8,269,025			3,700,407			(1,433,418	)		10,979,965
Operating income		240,115			1,060,554			514,472			—			1,815,141
Debt (expense) and refinancing charges		(502,762	)		(363,623	)		(43,449	)		401,992			(507,842	)
Other income, net		385,532			11,731			7,103			(401,992	)		2,374
Income tax expense		46,856			397,268			2,219			—			446,343
Equity earnings in subsidiaries		647,085			335,691			—			(982,776	)		—
Net income		723,114			647,085			475,907			(982,776	)		863,330
Less: Net income attributable to noncontrolling interests		—			—			—			(140,216	)		(140,216	)
Net income attributable to DaVita Inc.	$	723,114		$	647,085		$	475,907		$	(1,122,992	)	$	723,114

Consolidating Statements of Comprehensive Income

	DaVita Inc.			Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Consolidating Adjustments			Consolidated Total
For the year ended December 31, 2016
Net income	$	879,874		$	726,620	$	805,040		$	(1,378,452	)	$	1,033,082
Other comprehensive loss		(290	)		—		(29,337	)		—			(29,627	)
Total comprehensive income		879,584			726,620		775,703			(1,378,452	)		1,003,455
Less: Comprehensive income attributable to noncontrolling interest		—			—		—			(153,398	)		(153,398	)
Comprehensive income attributable to DaVita Inc.	$	879,584		$	726,620	$	775,703		$	(1,531,850	)	$	850,057
For the year ended December 31, 2015
Net income	$	269,732		$	195,507	$	476,354		$	(514,183	)	$	427,410
Other comprehensive loss		(10,920	)		—		(23,889	)		—			(34,809	)
Total comprehensive income		258,812			195,507		452,465			(514,183	)		392,601
Less: Comprehensive income attributable to noncontrolling interest		—			—		—			(157,678	)		(157,678	)
Comprehensive income attributable to DaVita Inc.	$	258,812		$	195,507	$	452,465		$	(671,861	)	$	234,923
For the year ended December 31, 2014
Net income	$	723,114		$	647,085	$	475,907		$	(982,776	)	$	863,330
Other comprehensive income (losses)		580			—		(22,952	)		—			(22,372	)
Total comprehensive income		723,694			647,085		452,955			(982,776	)		840,958
Less: Comprehensive income attributable to noncontrolling interest		—			—		—			(140,216	)		(140,216	)
Comprehensive income attributable to DaVita Inc.	$	723,694		$	647,085	$	452,955		$	(1,122,992	)	$	700,742

Consolidating Balance Sheets

	DaVita Inc.		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Consolidating Adjustments			Consolidated Total
As of December 31, 2016
Cash and cash equivalents	$	549,921	$	59,192	$	304,074	$	—		$	913,187
Accounts receivable, net		—		1,215,232		702,070		—			1,917,302
Other current assets		277,911		736,727		135,101		—			1,149,739
Total current assets		827,832		2,011,151		1,141,245		—			3,980,228
Property and equipment, net		337,200		1,689,798		1,148,369		—			3,175,367
Intangible assets, net		487		1,491,057		36,223		—			1,527,767
Investments in subsidiaries		9,717,728		2,002,660		—		(11,720,388	)		—
Intercompany receivables		3,250,692		—		866,955		(4,117,647	)		—
Other long-term assets and investments		39,994		86,710		523,874		—			650,578
Goodwill		—		7,838,984		1,568,333		—			9,407,317
Total assets	$	14,173,933	$	15,120,360	$	5,284,999	$	(15,838,035	)	$	18,741,257
Current liabilities	$	303,840	$	1,865,193	$	527,412	$	—		$	2,696,445
Intercompany payables		—		2,322,124		1,795,523		(4,117,647	)		—
Long-term debt and other long-term liabilities		8,614,445		1,215,315		392,053		—			10,221,813
Noncontrolling interests subject to put provisions		607,601		—		—		365,657			973,258
Total DaVita Inc. shareholders' equity		4,648,047		9,717,728		2,002,660		(11,720,388	)		4,648,047
Noncontrolling interests not subject to put provisions		—		—		567,351		(365,657	)		201,694
Total equity		4,648,047		9,717,728		2,570,011		(12,086,045	)		4,849,741
Total liabilities and equity	$	14,173,933	$	15,120,360	$	5,284,999	$	(15,838,035	)	$	18,741,257
As of December 31, 2015
Cash and cash equivalents	$	1,186,636	$	109,357	$	203,123	$	—		$	1,499,116
Accounts receivable, net		—		929,390		794,838		—			1,724,228
Other current assets		431,504		769,947		78,485		—			1,279,936
Total current assets		1,618,140		1,808,694		1,076,446		—			4,503,280
Property and equipment, net		268,066		1,575,890		944,784		—			2,788,740
Intangible assets, net		540		1,634,920		51,866		—			1,687,326
Investments in subsidiaries		8,893,079		1,597,185		—		(10,490,264	)		—
Intercompany receivables		3,474,133		—		701,814		(4,175,947	)		—
Other long-term assets and investments		74,458		53,346		113,246		—			241,050
Goodwill		—		7,834,257		1,460,222		—			9,294,479
Total assets	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875
Current liabilities	$	185,217	$	1,730,123	$	483,798	$	—		$	2,399,138
Intercompany payables		—		2,750,102		1,425,845		(4,175,947	)		—
Long-term debt and other long-term liabilities		8,730,673		1,130,988		305,838		—			10,167,499
Noncontrolling interests subject to put provisions		541,746		—		—		322,320			864,066
Total DaVita Inc. shareholders' equity		4,870,780		8,893,079		1,597,185		(10,490,264	)		4,870,780
Noncontrolling interests not subject to put provisions		—		—		535,712		(322,320	)		213,392
Total equity		4,870,780		8,893,079		2,132,897		(10,812,584	)		5,084,172
Total liabilities and equity	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875

Consolidating Statements of Cash Flows

	DaVita Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Consolidated Total
For the year ended December 31, 2016
Cash flows from operating activities:
Net income	$	879,874		$	726,620		$	805,040		$	(1,378,452	)	$	1,033,082
Changes in operating assets and liabilities and non-cash items included in net income		(614,642	)		335,166			(168,614	)		1,378,452			930,362
Net cash provided by operating activities		265,232			1,061,786			636,426			—			1,963,444
Cash flows from investing activities:
Additions of property and equipment, net		(139,303	)		(382,305	)		(307,487	)		—			(829,095	)
Acquisitions		—			(472,413	)		(91,443	)		—			(563,856	)
Proceeds from asset sales, net of cash divested		—			70,342			(5,617	)		—			64,725
Investments and other items		153,031			(29,038	)		2,565			—			126,558
Net cash provided by (used in) investing activities		13,728			(813,414	)		(401,982	)		—			(1,201,668	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(92,460	)		(27,830	)		(4,152	)		—			(124,442	)
Intercompany borrowing		237,988			(249,182	)		11,194			—			—
Other items		(1,061,203	)		(21,525	)		(144,811	)		—			(1,227,539	)
Net cash used in financing activities		(915,675	)		(298,537	)		(137,769	)		—			(1,351,981	)
Effect of exchange rate changes on cash		—			—			4,276			—			4,276
Net (decrease) increase in cash and cash equivalents		(636,715	)		(50,165	)		100,951			—			(585,929	)
Cash and cash equivalents at beginning of the year		1,186,636			109,357			203,123			—			1,499,116
Cash and cash equivalents at the end of the year	$	549,921		$	59,192		$	304,074		$	—		$	913,187
For the year ended December 31, 2015
Cash flows from operating activities:
Net income	$	269,732		$	195,507		$	476,354		$	(514,183	)	$	427,410
Changes in operating assets and liabilities and non-cash items included in net income		(146,531	)		688,106			74,032			514,183			1,129,790
Net cash provided by operating activities		123,201			883,613			550,386			—			1,557,200
Cash flows from investing activities:
Additions of property and equipment, net		(115,269	)		(319,695	)		(273,034	)		—			(707,998	)
Acquisitions		—			(76,983	)		(19,486	)		—			(96,469	)
Proceeds from asset sales		—			19,715			—			—			19,715
Investments and other items		(74,474	)		(2,144	)		(20,414	)		—			(97,032	)
Net cash used in investing activities		(189,743	)		(379,107	)		(312,934	)		—			(881,784	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		640,009			(11,953	)		(8,358	)		—			619,698
Intercompany borrowing		486,588			(394,735	)		(91,853	)		—			—
Other items		(572,295	)		(66,382	)		(119,991	)		—			(758,668	)
Net cash provided by (used in) financing activities		554,302			(473,070	)		(220,202	)		—			(138,970	)
Effect of exchange rate changes on cash		—			—			(2,571	)		—			(2,571	)
Net increase in cash and cash equivalents		487,760			31,436			14,679			—			533,875
Cash and cash equivalents at beginning of the year		698,876			77,921			188,444			—			965,241
Cash and cash equivalents at the end of the year	$	1,186,636		$	109,357		$	203,123		$	—		$	1,499,116

Consolidating Statements of Cash Flows

	DaVita Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Consolidated Total
For the year ended December 31, 2014
Cash flows from operating activities:
Net income	$	723,114		$	647,085		$	475,907		$	(982,776	)	$	863,330
Changes in operating assets and liabilities and non-cash items included in net income		(597,992	)		120,772			90,521			982,776			596,077
Net cash provided by operating activities		125,122			767,857			566,428			—			1,459,407
Cash flows from investing activities:
Additions of property and equipment, net		(51,374	)		(312,191	)		(277,765	)		—			(641,330	)
Acquisitions		—			(228,569	)		(43,525	)		—			(272,094	)
Proceeds from asset sales		—			8,791			—			—			8,791
Investments and other items		(333,803	)		(316	)		(38,977	)		—			(373,096	)
Net cash used in investing activities		(385,177	)		(532,285	)		(360,267	)		—			(1,277,729	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		4,513			(12,545	)		43			—			(7,989	)
Intercompany borrowing		410,437			(282,461	)		(127,976	)		—			—
Other items		(58,207	)		(14,099	)		(84,684	)		—			(156,990	)
Net cash provided by (used in) financing activities		356,743			(309,105	)		(212,617	)		—			(164,979	)
Effect of exchange rate changes on cash		—			—			2,293			—			2,293
Net increase (decrease) in cash and cash equivalents		96,688			(73,533	)		(4,163	)		—			18,992
Cash and cash equivalents at beginning of the year		602,188			151,454			192,607			—			946,249
Cash and cash equivalents at the end of the year	$	698,876		$	77,921		$	188,444		$	—		$	965,241

Additional Reporting Entities

Condensed Financial Statements Captions [Line Items]

Consolidating Statements of Income

Condensed Consolidating Statements of Income

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Patient services revenues	$	10,354,161		$	449,473		$	—		$	9,904,688
Less: Provision for uncollectible accounts		(451,353	)		(12,696	)		—			(438,657	)
Net patient service revenues		9,902,808			436,777			—			9,466,031
Capitated revenues		3,518,679			1,617,794			—			1,900,885
Other revenues		1,323,618			32,938			—			1,290,680
Total net revenues		14,745,105			2,087,509			—			12,657,596
Operating expenses and charges		12,850,562			2,035,001			110			10,815,451
Operating income		1,894,543			52,508			(110	)		1,842,145
Debt expense		(414,382	)		(10,140	)		—			(404,242	)
Other income, net		8,734			576			—			8,158
Income tax expense		455,813			10,643			(44	)		445,214
Net income		1,033,082			32,301			(66	)		1,000,847
Less: Net income attributable to noncontrolling interests		(153,208	)		—			—			(153,208	)
Net income attributable to DaVita Inc.	$	879,874		$	32,301		$	(66	)	$	847,639

Consolidating Statements of Comprehensive Income

Condensed Consolidating Statements of Comprehensive Income

	Consolidated Total			Physician Groups		Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Net income (losses)	$	1,033,082		$	32,301	$	(66	)	$	1,000,847
Other comprehensive losses		(29,627	)		—		—			(29,627	)
Total comprehensive income (losses)		1,003,455			32,301		(66	)		971,220
Less: Comprehensive income attributable to noncontrolling interest		(153,398	)		—		—			(153,398	)
Comprehensive income (losses) attributable to DaVita Inc.	$	850,057		$	32,301	$	(66	)	$	817,822

Consolidating Balance Sheets

Condensed Consolidating Balance Sheets

	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of December 31, 2016
Cash and cash equivalents	$	913,187	$	104,691	$	—	$	808,496
Accounts receivable, net		1,917,302		207,430		—		1,709,872
Other current assets		1,149,739		15,124		—		1,134,615
Total current assets		3,980,228		327,245		—		3,652,983
Property and equipment, net		3,175,367		1,378		—		3,173,989
Amortizable intangibles, net		1,527,767		4,858		—		1,522,909
Other long-term assets		650,578		78,215		2,714		569,649
Goodwill		9,407,317		16,405		—		9,390,912
Total assets	$	18,741,257	$	428,101	$	2,714	$	18,310,442
Current liabilities	$	2,696,445	$	223,302	$	—	$	2,473,143
Payables to parent		—		56,699		2,714		(59,413	)
Long-term debt and other long-term liabilities		10,221,813		44,094		—		10,177,719
Noncontrolling interests subject to put provisions		973,258		—		—		973,258
Total DaVita Inc. shareholders' equity		4,648,047		104,006		—		4,544,041
Noncontrolling interests not subject to put provisions		201,694		—		—		201,694
Shareholders' equity		4,849,741		104,006		—		4,745,735
Total liabilities and shareholder's equity	$	18,741,257	$	428,101	$	2,714	$	18,310,442

Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Cash flows from operating activities:
Net income	$	1,033,082		$	32,301		$	(66	)	$	1,000,847
Changes in operating and intercompany assets and liabilities and non-cash items included in net income		930,362			131,863			66			798,433
Net cash provided by operating activities		1,963,444			164,164			—			1,799,280
Cash flows from investing activities:
Additions of property and equipment		(829,095	)		(863	)		—			(828,232	)
Acquisitions and divestitures, net		(563,856	)		—			—			(563,856	)
Proceeds from asset sales		64,725			—			—			64,725
Investments and other items		126,558			(3,014	)		—			129,572
Net cash used in investing activities		(1,201,668	)		(3,877	)		—			(1,197,791	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(124,442	)		(4	)		—			(124,438	)
Intercompany		—			(143,837	)		—			143,837
Other items		(1,227,539	)		—			—			(1,227,539	)
Net cash used in financing activities		(1,351,981	)		(143,841	)		—			(1,208,140	)
Effect of exchange rate changes on cash		4,276			—			—			4,276
Net increase (decrease) in cash		(585,929	)		16,446			—			(602,375	)
Cash at beginning of the year		1,499,116			88,245			—			1,410,871
Cash at the end of the year	$	913,187		$	104,691		$	—		$	808,496